Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001023024-04-000003
Filing Date
2004-11-15
Accepted
2004-11-15 14:35:14
Documents
5
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE PHARMACEUTICALS 10Q-SB FOR Q3 2004 thirdquarter10q.htm 10QSB 635594
2 CERTIFICATION OF CEO exhibit31w1.htm EX-31.1 10835
3 CERTIFICATION OF CFO exhibit31w2.htm EX-31.2 10599
4 CERTIFICATION OF CEO exhibit32w1.htm EX-32.1 4405
5 CERTIFICATION OF CFO exhibit32w2.htm EX-32.2 5028
  Complete submission text file 0001023024-04-000003.txt   668608
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-31812 | Film No.: 041144145
SIC: 2836 Biological Products, (No Diagnostic Substances)